Cancer drug repurposed to fight rare, recurring joint tumor
Disease control
Completed
This study tested whether nilotinib, a drug used for leukemia, could help control a rare, non-cancerous joint tumor called pigmented villonodular synovitis (PVNS) when it comes back or spreads. Seventeen adults with recurrent or metastatic PVNS took nilotinib pills twice daily. T…
Phase: PHASE2 • Sponsor: Andrew J. Wagner, MD, PhD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC